HomeCompareMNMD vs JEPQ

MNMD vs JEPQ: Dividend Comparison 2026

MNMD yields 10.58% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $4.5K in total portfolio value
10 years
MNMD
MNMD
● Live price
10.58%
Share price
$18.91
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.2K
Annual income
$2,053.05
Full MNMD calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — MNMD vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNMDJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNMD + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNMD pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNMD
Annual income on $10K today (after 15% tax)
$899.00/yr
After 10yr DRIP, annual income (after tax)
$1,745.09/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, JEPQ beats the other by $84.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNMD + JEPQ for your $10,000?

MNMD: 50%JEPQ: 50%
100% JEPQ50/50100% MNMD
Portfolio after 10yr
$42.5K
Annual income
$2,102.81/yr
Blended yield
4.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MNMD right now

MNMD
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$28.00
+48.1% upside vs current
Range: $28.00 — $28.00
Altman Z
5.2
Piotroski
2/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNMD buys
0
JEPQ buys
0
No recent congressional trades found for MNMD or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNMDJEPQ
Forward yield10.58%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$40.2K$44.8K
Annual income after 10y$2,053.05$2,152.59
Total dividends collected$15.5K$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: MNMD vs JEPQ ($10,000, DRIP)

YearMNMD PortfolioMNMD Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$11,758$1,057.64$11,930$1,110.39$172.00JEPQ
2$13,743$1,162.18$14,133$1,224.34$390.00JEPQ
3$15,974$1,269.54$16,632$1,340.46$658.00JEPQ
4$18,472$1,379.15$19,454$1,457.97$982.00JEPQ
5$21,255$1,490.43$22,626$1,576.08$1.4KJEPQ
6$24,346$1,602.82$26,175$1,694.09$1.8KJEPQ
7$27,766$1,715.78$30,133$1,811.32$2.4KJEPQ
8$31,538$1,828.79$34,531$1,927.17$3.0KJEPQ
9$35,687$1,941.36$39,403$2,041.08$3.7KJEPQ
10$40,239$2,053.05$44,787$2,152.59$4.5KJEPQ

MNMD vs JEPQ: Complete Analysis 2026

MNMDStock

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Full MNMD Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this MNMD vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNMD vs SCHDMNMD vs JEPIMNMD vs OMNMD vs KOMNMD vs MAINMNMD vs XYLDMNMD vs QYLDMNMD vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.